TELA Bio, Inc. Retained Earnings
TELA Bio, Inc. (TELA) had Retained Earnings of -$421.10 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$421.10M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$409.83M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$397.56M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$388.52M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$421.10M 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$409.83M 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$397.56M 10-Q · filed 2026-08-11 |
| 2025-09-30 | -$388.52M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$379.92M 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$369.99M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$358.73M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$349.52M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$339.15M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$326.55M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$320.89M 10-K · filed 2025-03-21 |
| 2023-09-30 | -$308.00M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$297.04M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$286.25M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$274.23M 10-K · filed 2024-03-22 |
| 2022-09-30 | -$264.25M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$253.53M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$240.79M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$229.93M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$221.31M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$213.04M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$204.79M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$196.65M 10-K · filed 2022-03-23 |
| 2020-09-30 | -$188.86M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$181.16M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$175.08M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$167.86M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$160.40M 10-Q · filed 2019-12-18 |
| 2018-12-31 | -$137.86M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |